Increased potency and sustained suppressive actions of a new gonadotropin-releasing hormone (GnRH) antagonist peptide in man.

R. J. Urban; S. N. Pavlou; J. E. Rivier; W. W. Vale; M. L. Dufau; J. D. Veldhuis

Increased potency and sustained suppressive actions of a new gonadotropin-releasing hormone (GnRH) antagonist peptide in man.

R. J. Urban
, S. N. Pavlou
, J. E. Rivier
, W. W. Vale
, M. L. Dufau
, J. D. Veldhuis

Research output: Contribution to journal › Article › peer-review

Abstract

We have used a new potent GnRH antagonist to assess the efficacy of suppression of gonadotropin secretion in healthy postmenopausal women at three different doses. The Nal-Glu antagonist produced significant suppression of immunoactive and bioactive LH at a 300 micrograms/kg dose throughout the 30-hr sampling interval with only minimal local (skin) histamine release. This increased potency and decreased skin reactivity of the Nal-Glu antagonist make it a drug with potential clinical use similar to the GnRH agonist, but with the advantage of immediate gonadotropin suppression.

Original language	English (US)
Pages (from-to)	302-309
Number of pages	8
Journal	Transactions of the Association of American Physicians
Volume	101
State	Published - 1988
Externally published	Yes

Cite this

@article{9a980c8811724d70811430231e80fb6d,

title = "Increased potency and sustained suppressive actions of a new gonadotropin-releasing hormone (GnRH) antagonist peptide in man.",

abstract = "We have used a new potent GnRH antagonist to assess the efficacy of suppression of gonadotropin secretion in healthy postmenopausal women at three different doses. The Nal-Glu antagonist produced significant suppression of immunoactive and bioactive LH at a 300 micrograms/kg dose throughout the 30-hr sampling interval with only minimal local (skin) histamine release. This increased potency and decreased skin reactivity of the Nal-Glu antagonist make it a drug with potential clinical use similar to the GnRH agonist, but with the advantage of immediate gonadotropin suppression.",

author = "Urban, \{R. J.\} and Pavlou, \{S. N.\} and Rivier, \{J. E.\} and Vale, \{W. W.\} and Dufau, \{M. L.\} and Veldhuis, \{J. D.\}",

year = "1988",

language = "English (US)",

volume = "101",

pages = "302--309",

journal = "Transactions of the Association of American Physicians",

issn = "0066-9458",

}

TY - JOUR

T1 - Increased potency and sustained suppressive actions of a new gonadotropin-releasing hormone (GnRH) antagonist peptide in man.

AU - Urban, R. J.

AU - Pavlou, S. N.

AU - Rivier, J. E.

AU - Vale, W. W.

AU - Dufau, M. L.

AU - Veldhuis, J. D.

PY - 1988

Y1 - 1988

N2 - We have used a new potent GnRH antagonist to assess the efficacy of suppression of gonadotropin secretion in healthy postmenopausal women at three different doses. The Nal-Glu antagonist produced significant suppression of immunoactive and bioactive LH at a 300 micrograms/kg dose throughout the 30-hr sampling interval with only minimal local (skin) histamine release. This increased potency and decreased skin reactivity of the Nal-Glu antagonist make it a drug with potential clinical use similar to the GnRH agonist, but with the advantage of immediate gonadotropin suppression.

AB - We have used a new potent GnRH antagonist to assess the efficacy of suppression of gonadotropin secretion in healthy postmenopausal women at three different doses. The Nal-Glu antagonist produced significant suppression of immunoactive and bioactive LH at a 300 micrograms/kg dose throughout the 30-hr sampling interval with only minimal local (skin) histamine release. This increased potency and decreased skin reactivity of the Nal-Glu antagonist make it a drug with potential clinical use similar to the GnRH agonist, but with the advantage of immediate gonadotropin suppression.

UR - https://www.scopus.com/pages/publications/0024153585

UR - https://www.scopus.com/pages/publications/0024153585#tab=citedBy

M3 - Article

C2 - 3152021

AN - SCOPUS:0024153585

SN - 0066-9458

VL - 101

SP - 302

EP - 309

JO - Transactions of the Association of American Physicians

JF - Transactions of the Association of American Physicians

ER -

Increased potency and sustained suppressive actions of a new gonadotropin-releasing hormone (GnRH) antagonist peptide in man.

Abstract

Other files and links

Fingerprint

Cite this